These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7004007)

  • 1. [Bacteria and bacterial vaccines as nonspecific modulators of immunological reactivity].
    Prilepin NA; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Nov; (11):5-11. PubMed ID: 7004007
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological and nonimmunological mechanisms in the manifestations of infectious allergy].
    Maianskiĭ AN
    Zh Mikrobiol Epidemiol Immunobiol; 1979 May; (5):14-21. PubMed ID: 156480
    [No Abstract]   [Full Text] [Related]  

  • 3. Rationales for vaccines against leprosy.
    Bloom BR
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):505-9. PubMed ID: 6368414
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between delayed type hypersensitivity and protective immunity induced by mycobacterial vaccines in man.
    Fine PE; Pönnighaus JM; Maine NP
    Lepr Rev; 1986 Dec; 57 Suppl 2():275-83. PubMed ID: 3553800
    [No Abstract]   [Full Text] [Related]  

  • 5. Animal vaccination studies with Mycobacterium leprae.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):519-23. PubMed ID: 6368416
    [No Abstract]   [Full Text] [Related]  

  • 6. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy.
    Bretscher PA
    Immunol Today; 1992 Sep; 13(9):342-5. PubMed ID: 1466750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of bacteria with the immune system.
    Weir DM; Blackwell CC
    J Clin Lab Immunol; 1983 Jan; 10(1):1-12. PubMed ID: 6338236
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunological aspects of antibiotic therapy].
    Nikitin AV
    Antibiot Med Biotekhnol; 1985 Nov; 30(11):869-73. PubMed ID: 4091523
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of increasing tuberculin doses on the immunological reactivity of sensitized animals].
    Dzoldubaev YD
    Zdravookhr Kirg; 1978; (5):14-6. PubMed ID: 30230
    [No Abstract]   [Full Text] [Related]  

  • 10. [The modulation of cellular immunity in vivo and in vitro under the action of purified staphylococcal anatoxin].
    Semenova IB; Akatov AK
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):65-8. PubMed ID: 8067075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting the immune system: toward new vaccines against intracellular bacteria.
    Hess J; Schaible U; Raupach B; Kaufmann SH
    Adv Immunol; 2000; 75():1-88. PubMed ID: 10879281
    [No Abstract]   [Full Text] [Related]  

  • 12. Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity.
    Horwitz MA; Harth G; Dillon BJ; Maslesa-Galić S
    Vaccine; 2006 Jan; 24(4):443-51. PubMed ID: 16125825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of ascorbic acid in regulating immunological reactions].
    Pletsityĭ KD
    Vopr Pitan; 1979; (4):18-27. PubMed ID: 384669
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioengineering a bacterial pathogen to assemble its own particulate vaccine capable of inducing cellular immunity.
    Lee JW; Parlane NA; Wedlock DN; Rehm BH
    Sci Rep; 2017 Feb; 7():41607. PubMed ID: 28150705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ROLE OF VARIOUS ANTIGENIC PREPARATIONS OF FRANCISELLA TULARENSIS IN FORMATION OF ALLERGY REACTION IN HUMANS AND ANIMALS].
    Onoprienko NN; Aronova NV; Pavlovich NV
    Zh Mikrobiol Epidemiol Immunobiol; 2016; (1):22-9. PubMed ID: 27029112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Function of T cell subset in cell-mediated immunity].
    Fukazawa Y
    Nihon Saikingaku Zasshi; 1991 Jul; 46(4):785-804. PubMed ID: 1956113
    [No Abstract]   [Full Text] [Related]  

  • 17. Live bacterial vaccine vector and delivery strategies of heterologous antigen: A review.
    Ding C; Ma J; Dong Q; Liu Q
    Immunol Lett; 2018 May; 197():70-77. PubMed ID: 29550258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methodological approaches to designing chemical vaccines against bacterial infections].
    Kostiukova NN; Ezepchuk IuV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):3-8. PubMed ID: 6207689
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.
    Fine PE; Sterne JA; Pönnighaus JM; Rees RJ
    Lancet; 1994 Nov; 344(8932):1245-9. PubMed ID: 7967984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-pathogen interaction during bacterial vaccination.
    Barnett TC; Lim JY; Soderholm AT; Rivera-Hernandez T; West NP; Walker MJ
    Curr Opin Immunol; 2015 Oct; 36():1-7. PubMed ID: 25966310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.